Remodeling the Bone Marrow Microenvironment – A Proposal for Targeting Pro-inflammatory Contributors in MPN
Philadelphia-negative myeloproliferative neoplasms (MPN) are malignant bone marrow (BM) disorders, typically arising from a single somatically mutated hematopoietic stem cell. The most commonly mutated genes, JAK2, CALR, and MPL lead to constitutively active JAK-STAT signaling. Common clinical featu...
Main Authors: | Jonas Samuel Jutzi, Ann Mullally |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-08-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2020.02093/full |
Similar Items
-
MPN: The Molecular Drivers of Disease Initiation, Progression and Transformation and their Effect on Treatment
by: Julian Grabek, et al.
Published: (2020-08-01) -
The clinical relevance of broad mutational screening of myeloproliferative neoplasms at diagnosis
by: Helna Pettersson, et al.
Published: (2023-08-01) -
DLGAP1 directs megakaryocytic growth and differentiation in an MPL dependent manner in hematopoietic cells
by: Boguslaw A. Kwiatkowski, et al.
Published: (2019-07-01) -
Genomics of clonal evolution in a rare essential thrombocythemia with coexisting Type 2 CALR and MPL S204P mutations
by: Jing Wang, et al.
Published: (2023-12-01) -
Case report: Application of targeted NGS for the detection of non-canonical driver variants in MPN
by: Jin Zhang, et al.
Published: (2023-06-01)